Holen Sie sich die Stockscreener-App
40.74
0.71%
-0.29
Handel nachbörslich:
40.49
-0.25
-0.61%
Exelixis Inc Aktie (EXEL) Neueste Nachrichten
Is Improving Analyst Sentiment Reframing Exelixis (EXEL) Oncology Pipeline As A Core Valuation Anchor? - simplywall.st
Exelixis (EXEL) EVP awarded 52,018 RSUs vesting annually from May 2027 - Stock Titan
Exelixis (NASDAQ: EXEL) CEO granted RSUs, gifts 100K shares - Stock Titan
Forecasting The Future: 11 Analyst Projections For Exelixis - Benzinga
Exelixis stock falls after rival Merck trial shows better results - Investing.com
RBC Capital Lowers Exelixis (EXEL) Price Target to $43 | EXEL St - GuruFocus
Royal Bank Of Canada Issues Pessimistic Forecast for Exelixis (NASDAQ:EXEL) Stock Price - MarketBeat
Exelixis (NASDAQ:EXEL) Shares Down 9.4% After Analyst Downgrade - MarketBeat
RBC Lowers Price Target on Exelixis to $43 From $46, Keeps Sector Perform Rating - marketscreener.com
Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth With A 7.05% Potential Upside - DirectorsTalk Interviews
Exelixis (NASDAQ:EXEL) Downgraded by Wall Street Zen to Buy - MarketBeat
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - Nasdaq
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - The Motley Fool
Citigroup Inc. Sells 365,552 Shares of Exelixis, Inc. $EXEL - MarketBeat
EXEL PE Ratio & Valuation, Is EXEL Overvalued - Intellectia AI
Exelixis Director Julie Smith Sells Over 106K Shares - TradingView
Exelixis (NASDAQ:EXEL) EVP Dana Aftab Sells 47,918 Shares - MarketBeat
Exelixis (NASDAQ: EXEL) EVP sells 47,918 shares in open trade - Stock Titan
Exelixis EVP Sells Shares Worth Over $2 Million - TradingView
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion - Investing.com Nigeria
Intech Investment Management LLC Grows Stake in Exelixis, Inc. $EXEL - MarketBeat
Exelixis Inc (NASDAQ:EXEL) Presents a Compelling Value Investment Case - ChartMill
Is It Too Late To Consider Exelixis (EXEL) After Its Surging Share Price? - Yahoo Finance
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March 2026 - BioSpace
Exelixis Cancer Pipeline Progress Puts Focus On Valuation And Growth Potential - Yahoo Finance
EXEL (NASDAQ: EXEL) insider Dana T Aftab sells 29,873 shares for $1.32M - Stock Titan
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March - Business Wire
Oncology Market Set to Nearly Triple: Here Are Five Companies Le - GuruFocus
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge - PR Newswire
Responsive Playbooks and the EXEL Inflection - Stock Traders Daily
Here's Why Exelixis (EXEL) is a Strong Momentum Stock - Yahoo Finance
Exelixis reports solid earnings – are new highs back on the table? - MSN
Exelixis (NASDAQ:EXEL) EVP Dana Aftab Sells 29,873 Shares - MarketBeat
Exelixis (EXEL) R&D EVP sells 29,873 shares at $44.35 - Stock Titan
Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Leader With 8.11% Potential Upside - DirectorsTalk Interviews
Exelixis (EXEL) Q4 2025 Earnings Call Transcript - AOL.com
Vanguard Group Inc. Lowers Position in Exelixis, Inc. $EXEL - MarketBeat
Advisors Preferred LLC Purchases 33,344 Shares of Exelixis, Inc. $EXEL - MarketBeat
Exelixis (NASDAQ:EXEL) Upgraded at Wall Street Zen - MarketBeat
Will Exelixis Inc. outperform its industry peersTrade Exit Report & AI Optimized Trading Strategy Guides - mfd.ru
Exelixis (NASDAQ:EXEL) Director Jack Wyszomierski Sells 99,574 Shares - MarketBeat
Exelixis director Wyszomierski sells $4.38 million in stock By Investing.com - Investing.com UK
Exelixis director Wyszomierski sells $4.38 million in stock - Investing.com
Exelixis (EXEL) director sells 99,574 shares after option exercise - Stock Titan
Published on: 2026-02-21 01:41:50 - mfd.ru
Exelixis: The Cash‑Generating Biotech That I Think Deserves a Closer Look in 2026 - Nasdaq
Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
Jupiter Asset Management Ltd. Boosts Holdings in Exelixis, Inc. $EXEL - MarketBeat
Christopher Senner Sells 30,617 Shares of Exelixis (NASDAQ:EXEL) Stock - Defense World
Brenda Hefti Sells 18,669 Shares of Exelixis (NASDAQ:EXEL) Stock - Defense World
Exelixis EVP Haley sells $2.95 million in stock By Investing.com - Investing.com Nigeria
Exelixis director Smith sells $4.68m in stock after option exercise By Investing.com - Investing.com Canada
Exelixis director Smith sells $4.68m in stock after option exercise - Investing.com UK
Exelixis Inc. (NASDAQ:EXEL) Stands Out as a Quality Investing Candidate - ChartMill
Exelixis director Eckhardt sells $168k in stock By Investing.com - Investing.com Canada
Exelixis EVP Haley sells $2.95 million in stock - Investing.com
Exelixis director Eckhardt sells $168k in stock - Investing.com
5.71%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):